User profiles for Andres Merits
 | Andres MeritsProfessor of Applied Virology, University of Tartu Verified email at ut.ee Cited by 12344 |
Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen
Re-emergence of chikungunya virus, a mosquito-transmitted pathogen, is of serious public
health concern. In the past 15 years, after decades of infrequent, sporadic outbreaks, the …
health concern. In the past 15 years, after decades of infrequent, sporadic outbreaks, the …
Novel activities of safe-in-human broad-spectrum antiviral agents
…, I Julkunen, O Vapalahti, T Tenson, A Merits… - Antiviral research, 2018 - Elsevier
According to the WHO, there is an urgent need for better control of viral diseases. Re-positioning
existing safe-in-human antiviral agents from one viral disease to another could play a …
existing safe-in-human antiviral agents from one viral disease to another could play a …
Therapeutics and vaccines against chikungunya virus
Currently, there are no licensed vaccines or therapies available against chikungunya virus (CHIKV),
and these were subjects discussed during a CHIKV meeting recently organized in …
and these were subjects discussed during a CHIKV meeting recently organized in …
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
Remdesivir (RDV), a broadly acting nucleoside analogue, is the only FDA approved small
molecule antiviral for the treatment of COVID-19 patients. To date, there are no reports …
molecule antiviral for the treatment of COVID-19 patients. To date, there are no reports …
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research
The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide …
the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide …
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays
Chikungunya virus (CHIKV), an alphavirus, has recently caused epidemic outbreaks and is
therefore considered a re-emerging pathogen for which no effective treatment is available. In …
therefore considered a re-emerging pathogen for which no effective treatment is available. In …
Identification of a novel function of the alphaviruscapping apparatus: RNA 5′-TRIPHOSPHATASE ACTIVITY OF Nsp2
Both genomic and subgenomic RNAs of theAlphavirus have m 7 G(5′)ppp(5′)N (cap0
structure) at their 5′ end. Previously it has been shown thatAlphavirus-specific nonstructural …
structure) at their 5′ end. Previously it has been shown thatAlphavirus-specific nonstructural …
A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice
Chikungunya virus (CHIKV) is an alphavirus that causes chronic and incapacitating
arthralgia in humans. Injury to the joint is believed to occur because of viral and host immune-…
arthralgia in humans. Injury to the joint is believed to occur because of viral and host immune-…
Viperin restricts chikungunya virus replication and pathology
Chikungunya virus (CHIKV) is a mosquito-borne arthralgia arbovirus that is reemergent in
sub-Saharan Africa and Southeast Asia. CHIKV infection has been shown to be self-limiting, …
sub-Saharan Africa and Southeast Asia. CHIKV infection has been shown to be self-limiting, …
[PDF][PDF] Host inflammatory response to mosquito bites enhances the severity of arbovirus infection
…, E Pondeville, E Schnettler, A Kohl, A Merits… - Immunity, 2016 - cell.com
Aedes aegypti mosquitoes are responsible for transmitting many medically important viruses
such as those that cause Zika and dengue. The inoculation of viruses into mosquito bite …
such as those that cause Zika and dengue. The inoculation of viruses into mosquito bite …
